In the Press

Officials from the US Centers for Disease Control and Prevention (CDC) said today that, following its alert 2 weeks ago, it has received 109 reports of unexplained hepatitis in young children from 24 states and Puerto Rico.

The US Food and Drug Administration (FDA) yesterday severely restricted use of the Johnson & Johnson (J&J) COVID-19 vaccine as federal budget documents herald a vaccine shortage this fall if second boosters are widely encouraged.

As China battles Omicron-driven activity in some of its biggest cities, health officials in Shanghai today said its outbreak is under control, as later-affected Beijing tightened measures in a hot spot district.

Getting sick with a common cold doesn't make you immune to COVID-19, but a COVID-19 infection might, at least temporarily, boost the number of antibodies you have against common cold-causing coronaviruses and the SARS-CoV-1 and MERS-CoV viruses, all of which are closely related. Scientists at Scripps Research have now characterized coronavirus antibodies isolated from 11 people to reveal how COVID-19 impacts the immune system's ability to recognize other coronaviruses

Road transport allows all forms of land conditions to be met at less cost. Because of this function, despite numerous disadvantages, it becomes the most frequently used method of transport, especially in underdeveloped or developing countries.

Though global COVID-19 cases overall continue to fall, illness levels rose in Africa and the Americas for the second week in a row, led by a trio of Omicron subvariants, the World Health Organization (WHO) said today in its weekly pandemic update.

As we warm up for world hand hygiene day tomorrow, it’s a good time to have a talk about gloves.

It is well established that older adults are more susceptible to infection and their immune systems less capable of generating a strong immune response. Now, a new University of Arizona Health Sciences-led paper explains why, which could lead to potential interventions.

COVID-19 patients already on ventilators don't benefit from remdesivir, but the antiviral drug offers a slight reduction in death or progression to ventilation among other hospitalized patients, according to final results from the adaptive World Health Organization's (WHO's) Solidarity randomized trial and an updated meta-analysis.

In highly anticipated findings today, the technical advisory group for the World Health Organization (WHO) released excess death data for 2020 and 2021, which suggest that the real COVID-19 number is nearly three times higher than officially reported. The report also revealed other key trends, including that the pandemic has been deadlier for men and has exposed gaps in reporting.